CHMP recommends Medac's generic Zometa, clears infected MabThera, seeks harmony
This article was originally published in Scrip
Executive Summary
The EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended for approval German firm Medac's generic version of Novartis' Zometa (Zoledronic acid).